Navigation Links
Slone Partners Hosts Precision Medicine Event Led by Michael Pellini, MD with Panelists Troy Cox, Barbara Weber, MD and Roman Yelensky, PhD
Date:6/14/2017

Slone Partners welcomed a panel of premier industry leaders on June 8th to discuss the initiative steered by the executive search firm, “Building Value in Precision Medicine: Can We Overcome the Obstacles?”

Michael Pellini, MD, Chairman of the Board of Directors of Foundation Medicine, led an open discussion with expert panelists Troy Cox, CEO of Foundation Medicine, Barbara Weber, MD, Interim CEO at Tango Therapeutics, and Roman Yelensky, PhD, Chief Technology Officer, Gritstone Oncology.

The panel reviewed the state of the Precision Medicine arena and shared approaches on developing strategic methods and collaborative partnerships to improve patient outcomes. They addressed the extreme challenge of recruiting patients for clinical trials and producing meaningful results with a small group.

“The event was a real success and the topics and opinions shared about the future of diagnostics and personalized medicine were timely and valuable. As a major player and participant in the Precision Medicine space, Slone Partners wants to create opportunities for its client partners and the next generation of industry leaders to find solutions and answers to their concerns,” said Slone Partners Founder, Adam Slone.

The attendees listened to a passionate panel of experts who shared their thoughts on the complex issues and future of personalized medicine and diagnostics. Key topics on the agenda included targeted therapies and the need for increased targeted genetic sequencing in cancer patients. The panelists touched on a tumor-specific approach to finding the right patients for the right treatment rather than a broader disease-specific approach.

“Cancer is a genetic disease and there is no substitute for sequencing every patient’s tumor to find the right treatment and better understand drug resistance and why patients relapse,” stated Tango Therapeutics Interim CEO, Barbara Weber, MD.

“Our goal has been achieved as participants acquired meaningful insights into the Precision Medicine space. Slone Partners will continue to support the advancement of the Precision Medicine industry by hosting more events like this one, bringing together key decision makers and driving the conversation around major issues,” said Slone Partners President, Tara Kochis-Stach.

About Slone Partners

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the life sciences, diagnostics, clinical trials, contract research, therapeutics, healthcare information technology, and laboratory testing industries with offices in Boston, Washington, D.C. and San Francisco. Innovative, world-class organizations from across the nation have chosen Slone Partners to fill their key positions.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14424453.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Slone Partners Pledges its Support as Corporate Benefactor for the 2017 Executive War College
2. Slone Partners Places Chief Executive Officer at La Peer Health Systems
3. Slone Partners Places Chief Executive Officer at Avomeen Analytical Services
4. Slone Partners Designated by Hunt Scanlon Media as one of the “Top 50 Healthcare and Life Science Search Firms”
5. Slone Partners Places President & Chief Commercial Officer at GenePeeks
6. Slone Partners Sponsors the SCOPE Summit for Clinical Ops Executives 2017
7. Slone Partners Fills Head of Sales at Optimal Medicine
8. Executive Search Firm Slone Partners Expands With New San Francisco Office
9. Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation
10. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
11. NDA Partners Announces Collaboration Agreement with Qualiminds Corporate Services of Mumbai India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... RPS ... clinical study that demonstrates the accuracy of the FebriDx® test, a commercially-ready, ... acute bacterial and viral respiratory tract infections by testing the body’s immune ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia ... be hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” ... pathology adoption best practices and how Proscia improves lab economics and realizes an ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
Breaking Biology Technology:
(Date:5/23/2017)... Italy , May 23, 2017  Hunova, the first robotic gym ... trunk, has been officially launched in Genoa, Italy . ... Europe and the USA . The technology ... on the market by the IIT spin-off Movendo Technology thanks to a ... the Multimedia News Release, please click: ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
Breaking Biology News(10 mins):